Resveratrol and ivacaftor are additive G551D CFTR-channel potentiators: therapeutic implications for cystic fibrosis sinus disease.

MLA

Cho, Do-Yeon, et al. “Resveratrol and Ivacaftor Are Additive G551D CFTR-Channel Potentiators: Therapeutic Implications for Cystic Fibrosis Sinus Disease.” International Forum of Allergy & Rhinology, vol. 9, no. 1, Jan. 2019, pp. 100–05. EBSCOhost, https://doi.org/10.1002/alr.22202.

APA

Cho, D.-Y., Zhang, S., Lazrak, A., Grayson, J. W., Peña Garcia, J. A., Skinner, D. F., Lim, D. J., Mackey, C., Banks, C., Matalon, S., & Woodworth, B. A. (2019). Resveratrol and ivacaftor are additive G551D CFTR-channel potentiators: therapeutic implications for cystic fibrosis sinus disease. International Forum of Allergy & Rhinology, 9(1), 100–105. https://doi.org/10.1002/alr.22202

Chicago

Cho, Do-Yeon, Shaoyan Zhang, Ahmed Lazrak, Jessica W Grayson, Jaime A Peña Garcia, Daniel F Skinner, Dong Jin Lim, et al. 2019. “Resveratrol and Ivacaftor Are Additive G551D CFTR-Channel Potentiators: Therapeutic Implications for Cystic Fibrosis Sinus Disease.” International Forum of Allergy & Rhinology 9 (1): 100–105. doi:10.1002/alr.22202.